Quarterly Results

  • Company Name :
Astrazeneca Pharma India Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 506820
  • NSE Symbol:
  • ASTRAZEN
  • P/E(TTM):
  • 99.62
  • ISIN Demat:
  • INE203A01020
  • Div & Yield%:
  • 0.35
  • EPS(TTM):
  • 92.47
  • Book Value(₹):
  • 319.60
  • Market Cap(₹Cr.):
  • 23,028.75
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 559.09 526.31 480.48
Excise Duty 0.00 0.00 0.00
Net Sales 559.09 526.31 480.48
Other Operating Income 0.00 0.00 0.00
Other Income 6.17 11.24 16.15
Total Income 565.26 537.55 496.63
Total Expenditure 489.20 445.56 399.79
PBIDT 76.06 91.99 96.84
Interest 0.67 0.72 0.68
PBDT 75.39 91.27 96.16
Depreciation 2.57 16.57 17.69
Tax 19.01 22.10 22.92
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.41 -3.23 -2.70
Reported Profit After Tax 54.22 55.83 58.25
Extra-ordinary Items -3.91 -0.25 -4.02
Adjusted Profit After Extra-ordinary item 58.13 56.08 62.27
EPS (Unit Curr.) 21.69 22.33 23.30
EPS (Adj) (Unit Curr.) 21.69 22.33 23.30
Calculated EPS (Unit Curr.) 21.69 22.33 23.30
Calculated EPS (Adj) (Unit Curr.) 21.69 22.33 23.30
Calculated EPS (Ann.) (Unit Curr.) 86.75 89.33 93.20
Calculated EPS (Adj) (Ann.) (Unit Curr.) 86.75 89.33 93.20
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 5.00 5.00 5.00
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 13.60 17.48 20.15
PBDTM(%) 13.48 17.34 20.01
PATM(%) 9.70 10.61 12.12